$Novo Nordisk AS(NVO.US)$Unitedhealth(UNH.US)Remain bullish in the short term, the reason is reasonable valuation repair with good chip distribution. Tech stocks are too high, while this side has low valuation and fewer chips in the local range, so just trade here. Novo Nordisk remains bullish to around 59. Today, plan to sell 2 0919 60calls to make the cost negative and let profits run, and sell 1 260116 80call to reduce costs. The underlying stock will not move until reaching the 59 target. UnitedHealth stood firm at the 300 node last Friday with the help of Buffett's position-building news. In the short term, valuation repair continues. Personally, the reasonable valuation is around 350. Further upside will need improved performance and other positive news. Other operations include selling the 1017 250call of TSMC bought last Friday at the bottom during the session, freeing up funds to prepare for buying the dip on $Rocket Lab USA(RKLB.US) 260116 50call. This stock was highly recommended by Boss' Boss. After careful research over the weekend, it is indeed considered to have investment value. The underlying stock was bought at the pre-market low, and opportunities to buy the dip will be taken to add positions in batches. Microsoft's short-term trend is too weak, so calls will remain unchanged for now, waiting for a bottom signal.